Xeris Biopharma Holdings Inc — Cash Flow (NASDAQ:XERS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities 95.53 M102.89 M47.02 M36.98 M 6.61 M Cash from investing activities 97.96 M34.46 M6 M4.88 M 113 K Cash from financing activities 27.25 M127.47 M1.61 M36.17 M 12.05 M Free cash flow 94.45 M102.89 M47.02 M36.98 M 6.61 M

Noticias

Xeris Pharmaceuticals enfrenta prueba de resultados mientras acelera su crecimiento

Xeris Pharmaceuticals enfrenta prueba de ganancias con crecimiento acelerado

Xeris Pharmaceuticals faces earnings test as growth accelerates

Why Are Shares Of Xeris Biopharma Falling Friday? - Xeris Biopharma Holdings (NASDAQ:XERS)

BioCryst Pharmaceuticals (BCRX) Q4 Earnings and Revenues Surpass Estimates

Director de Xeris Biopharma vende acciones por 176.000 dólares

Director de Xeris Biopharma vende acciones por $176,000

Xeris Biopharma director Shannon sells $176k in shares

Outlook Therapeutics, Intelligent Bio Solutions And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Biohaven (NYSE:BHVN), Cango (NYSE:CANG)

Las acciones de Xeris Pharmaceuticals suben mientras el fármaco rival enfrenta revés de la FDA

Acciones de Xeris Pharmaceuticals suben tras revés de la FDA para medicamento rival

Xeris Pharmaceuticals stock rises as rival drug faces FDA setback